Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
FONR 
Fonar Corporation (FONR)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/12/2025: FONR (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit 1.64% | Avg. Invested days 41 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/12/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 93.69M USD | Price to earnings Ratio 11.9 | 1Y Target Price - |
Price to earnings Ratio 11.9 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 1 | 52 Weeks Range 12.00 - 18.68 | Updated Date 06/29/2025 |
52 Weeks Range 12.00 - 18.68 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.25 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 8.19% | Operating Margin (TTM) 13.48% |
Management Effectiveness
Return on Assets (TTM) 3.54% | Return on Equity (TTM) 6.91% |
Valuation
Trailing PE 11.9 | Forward PE - | Enterprise Value 78089814 | Price to Sales(TTM) 0.91 |
Enterprise Value 78089814 | Price to Sales(TTM) 0.91 | ||
Enterprise Value to Revenue 0.76 | Enterprise Value to EBITDA 3.37 | Shares Outstanding 6168460 | Shares Floating 6030734 |
Shares Outstanding 6168460 | Shares Floating 6030734 | ||
Percent Insiders 2.45 | Percent Institutions 49.08 |
Upturn AI SWOT
Fonar Corporation
Company Overview
History and Background
Fonar Corporation was founded in 1978 by Dr. Raymond Damadian, inventor of the first MRI scanner. The company pioneered MRI technology and focused on developing upright MRI systems.
Core Business Areas
- MRI Scanner Manufacturing: Designs, manufactures, and sells MRI scanners, specializing in Upright MRI technology.
- MRI Service and Support: Provides service, maintenance, and repair services for MRI scanners.
- Physician Management Services: Manages medical facilities and provides administrative and operational support.
Leadership and Structure
Dr. Raymond Damadian founded the company, however, as of June 16, 2024, the leader is not known. The organizational structure consists of departments focused on R&D, manufacturing, sales & marketing, service, and administration.
Top Products and Market Share
Key Offerings
- Upright MRI: Fonar's flagship product. Allows patients to be scanned in weight-bearing positions. Competitors include Siemens, GE Healthcare, and Philips but they do not have upright MRI offerings. Revenue not publicly broken down.
- FONAR UPRIGHT Multi-Position MRI: A unique MRI that allows patients to be scanned in multiple positions including standing, sitting, and lying down. Competitors include Siemens, GE Healthcare, and Philips. Revenue not publicly broken down.
- STAND-UP MRI: STAND-UP MRI stands out in the imaging landscape. It distinguishes itself by performing scans in the weight-bearing position. Competitors include Siemens, GE Healthcare, and Philips. Revenue not publicly broken down.
Market Dynamics
Industry Overview
The MRI market is competitive and growing, driven by increasing demand for diagnostic imaging. Technological advancements and the aging population contribute to market expansion.
Positioning
Fonar holds a niche position with its Upright MRI technology, differentiating itself from larger competitors focused on traditional MRI systems.
Total Addressable Market (TAM)
The global MRI market size is projected to reach over $9 billion by 2028. Fonar's positioning in the upright MRI niche allows it to target a segment of this overall market.
Upturn SWOT Analysis
Strengths
- Unique Upright MRI technology
- Pioneering experience in MRI
- Strong brand recognition in niche market
Weaknesses
- Smaller market share compared to major competitors
- Limited product portfolio
- High reliance on a single key product line
Opportunities
- Expanding into new geographic markets
- Developing new applications for Upright MRI technology
- Partnering with other healthcare providers
Threats
- Competition from larger players with greater resources
- Technological obsolescence
- Changes in healthcare regulations
Competitors and Market Share
Key Competitors
- GE (GE)
- Siemens (SIEGY)
- Philips (PHG)
Competitive Landscape
Fonar's advantage is its unique Upright MRI, but its disadvantages include limited resources and smaller scale compared to its larger competitors.
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends can be found in their investor relations reports.
Future Projections: Future projections are available in the company's financial statements.
Recent Initiatives: Review their press releases on their website.
Summary
Fonar Corporation specializes in the niche market of upright MRI technology, offering a unique diagnostic imaging solution. While it faces stiff competition from larger, well-established companies, its innovative product and niche market presence give it a competitive edge. Fonar's long-term success depends on its ability to expand its market reach, develop new applications for its technology, and navigate the changing healthcare landscape. It must watch the larger competitors and look for market disruption or other healthcare landscape changes.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- Market Research Reports
- Financial News Outlets
Disclaimers:
This analysis is based on publicly available information and is not financial advice. Market share data is estimated.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Fonar Corporation
Exchange NASDAQ | Headquaters Melville, NY, United States | ||
IPO Launch date 1987-01-01 | Chairman, President, CEO & Treasurer Mr. Timothy R. Damadian M.D. | ||
Sector Healthcare | Industry Diagnostics & Research | Full time employees 520 | Website https://www.fonar.com |
Full time employees 520 | Website https://www.fonar.com | ||
FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, and selling magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States. It operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. The company offers Upright MRI scanner, allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. It also provides non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. In addition, the company owns and operates diagnostic imaging facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1978 and is based in Melville, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.